tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cochlear Limited Unveils Revolutionary Nucleus Nexa System

Story Highlights
  • Cochlear Limited introduces the Nucleus Nexa System with upgradeable firmware.
  • The Nucleus 8 Nexa Sound Processor offers convenience with its compact design and long battery life.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cochlear Limited Unveils Revolutionary Nucleus Nexa System

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Cochlear ( (AU:COH) ) just unveiled an update.

Cochlear Limited has announced the Nucleus Nexa System, a groundbreaking cochlear implant system featuring upgradeable firmware, which allows users to access future innovations seamlessly. The Nucleus 8 Nexa Sound Processor, noted for being the smallest and lightest with an all-day battery life, enhances patient convenience by securely storing hearing settings on the implant, reducing the need for clinic visits.

The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.

More about Cochlear

Cochlear Limited operates in the medical device industry, specializing in cochlear implants and sound processors. The company focuses on innovations that enhance hearing experiences for individuals with hearing impairments.

Average Trading Volume: 173,116

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$20.4B

Learn more about COH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1